New Star

Anhui New Star Pharmaceutical Development Co., Ltd. is a private high-tech pharmaceutical company based in Hefei, China, specializing in the research, development, and manufacture of innovative medicines and fine chemicals. Founded in the late 1990s, the company focuses on small molecule drug discovery across therapeutic areas such as pain management, metabolic diseases, and bone health. Its pipeline includes several clinical-stage programs, most notably tapentadol hydrochloride for pain and minodronic acid for osteoporosis. New Star Pharmaceutical operates as a vertically integrated entity, leveraging its R&D capabilities to develop new chemical entities and generic formulations that are produced in collaboration with various manufacturing partners across China.